Carole Ho - Jan 9, 2023 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Jan 9, 2023
Transactions value $
-$41,552
Form type
4
Date filed
1/10/2023, 03:51 PM
Previous filing
Jan 9, 2023
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$41.6K -1.46K -0.82% $28.48 177K Jan 9, 2023 See footnote F1, F2
holding DNLI Common Stock 25K Jan 9, 2023 See footnote F3
holding DNLI Common Stock 131K Jan 9, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 The shares are held of record by the Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 Includes 131,057 RSUs.